Taro Pharmaceutical Industries
(NYSE) TARO
Taro Pharmaceutical Industries Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$629.18M
Net Income (TTM)
$53.87M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
TARO News
Taro Calls Off Merger With Sun
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Taro Pharmaceutical Industries
Industry
Pharmaceuticals
Sector
Health CareEmployees
1,554
CEO
Uday Vijaykumar Baldota, MBA
Website
www.taro.comHeadquarters
Haifa, 2624761, IL
TARO Financials
Key Financial Metrics (TTM)
Gross Margin
48%
Operating Margin
3%
Net Income Margin
9%
Return on Equity
3%
Return on Capital
1%
Return on Assets
2%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$304.98M
Operating Income
$21.51M
EBITDA
$38.40M
Operating Cash Flow
$132.39M
Capital Expenditure
$54.22M
Free Cash Flow
$78.17M
Cash & ST Invst.
$879.35M
Total Debt
$0.00
Taro Pharmaceutical Industries Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$164.94M
+12.5%
Gross Profit
$87.39M
+15.4%
Gross Margin
52.98%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
1,554
N/A
Net Income
$15.08M
+118.1%
EBITDA
$18.06M
-10.1%
Quarterly Fundamentals
Net Cash
$879.35M
+3.7%
Accounts Receivable
$177.46M
-26.6%
Inventory
$204.82M
-9.6%
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
-100.0%
Return on Assets
2.49%
N/A
Return on Invested Capital
1.19%
N/A
Free Cash Flow
$36.30M
-24.6%
Operating Cash Flow
$44.24M
-21.9%